Sabrient Leaders In Investment Research CYANOTECH HOLD RATING. Company Profile. Sabrient Analysis. Stock Fundamentals as of May 7, 2018

Similar documents
Sabrient Leaders In Investment Research PSYCHIATRIC SOLUTIONS INC. Company Profile. Sabrient Analysis. Stock Fundamentals as of July 27, 2009

Sabrient Leaders In Investment Research ENERSIS SA (ADR) Company Profile. Sabrient Analysis. Stock Fundamentals as of December 14, 2009

Sabrient Leaders In Investment Research HEALTH CARE PROPERTY INVESTORS. Company Profile. Sabrient Analysis. Stock Fundamentals as of January 19, 2010

Sabrient Leaders In Investment Research RESEARCH IN MOTION LTD. Company Profile. Sabrient Analysis. Stock Fundamentals as of January 19, 2010

Sabrient Leaders In Investment Research MEADWESTVACO CORP SELL RATING. Company Profile. Sabrient Analysis. Stock Fundamentals as of September 14, 2009

Sabrient Leaders In Investment Research CNH GLOBAL NV (ADR) Company Profile. Sabrient Analysis. Stock Fundamentals as of January 19, 2010

Last week's rating: C Marketperform Percentile Ranking: 60 Data as of 10/12/2018

Last week's rating: C Marketperform Percentile Ranking: 53 Data as of 07/06/2018

W H I T E P A P E R. Sabrient Multi-cap Insider/Analyst Quant-Weighted Index DAVID BROWN CHIEF MARKET STRATEGIST

Dividend Growth as a Defensive Equity Strategy August 24, 2012

DWAS Invesco DWA SmallCap Momentum ETF

SCIJ Global X Scientific Beta Japan ETF

The Compelling Case for Value

RFFC RiverFront Dynamic U.S. Flex-Cap ETF

Aspiriant Risk-Managed Equity Allocation Fund RMEAX Q4 2018

USMF WisdomTree U.S. Multifactor Fund

PSI Invesco Dynamic Semiconductors ETF

VXF Vanguard Extended Market ETF

MAGA Point Bridge GOP Stock Tracker ETF

Smart Beta and the Evolution of Factor-Based Investing

ROUS Hartford Multifactor US Equity ETF

IVOG Vanguard S&P Mid-Cap 400 Growth ETF

FDM First Trust Dow Jones Select MicroCap Index Fund

PSCC Invesco S&P SmallCap Consumer Staples ETF

Proof Is in Performance Thru 3Q17

DVY ishares Select Dividend ETF

SPHQ Invesco S&P 500 Quality ETF

FQAL Fidelity Quality Factor ETF

FJP First Trust Japan AlphaDEX Fund

USEQ Invesco Russell 1000 Enhanced Equal Weight ETF

Total

PKB Invesco Dynamic Building & Construction ETF

RYU Invesco S&P 500 Equal Weight Utilities ETF

VLUE ishares Edge MSCI U.S.A. Value Factor ETF

Factor Mixology: Blending Factor Strategies to Improve Consistency

XHE SPDR S&P Health Care Equipment ETF

PDP Invesco DWA Momentum ETF

SPMD SPDR Portfolio Mid Cap ETF

FIW First Trust Water ETF

Sample Report PERFORMANCE REPORT I YOUR FUND

IJK ishares S&P Mid-Cap 400 Growth ETF

52-Week High Trailing PE Week Low Forward PE Buy 17 Analysts. 1-Year Return: 33.6% 5-Year Return: 36.

PXSG Invesco Russell 2000 Pure Growth ETF

VNLA Janus Henderson Short Duration Income ETF

VTV Vanguard Value ETF

Equity Rating and Report

IVE ishares S&P 500 Value ETF

FKO First Trust South Korea AlphaDEX Fund

SPLV Invesco S&P 500 Low Volatility ETF

USLB Invesco Russell 1000 Low Beta Equal Weight ETF

SPXE ProShares S&P 500 Ex-Energy ETF

VTWV Vanguard Russell 2000 Value ETF

SCHV Schwab U.S. Large-Cap Value ETF

XES SPDR S&P Oil & Gas Equipment & Services ETF

Last week's rating: A Strongly Outperform Percentile Ranking: 1 Data as of 01/19/2018. Sample

UTES Reaves Utilities ETF

An introduction to Invesco s Equity Long/Short Strategies

DESC Xtrackers Russell 2000 Comprehensive Factor ETF

RORE Hartford Multifactor REIT ETF

Mid Cap Dividend Growth Strategy

EWI ishares MSCI Italy ETF

XBI SPDR S&P BIOTECH ETF

OMFS Oppenheimer Russell 2000 Dynamic Multifactor ETF

SPYD SPDR Portfolio S&P 500 High Dividend ETF

SPYV SPDR Portfolio S&P 500 Value ETF

BROAD COMMODITY INDEX

PSET Principal Price Setters Index ETF

SPYD SPDR Portfolio S&P 500 High Dividend ETF

CIT Group Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (CIT-NYSE)

GEM Goldman Sachs ActiveBeta Emerging Markets Equity ETF

ACSI American Customer Satisfaction ETF

ITOT ishares Core S&P Total U.S. Stock Market ETF

ETF Global Quant Equity 10

Healthways Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (HWAY-NASDAQ) SUMMARY

EQWS Invesco Russell 2000 Equal Weight ETF

Multi Asset Indices Selection and Rebalance Dates

(PGR-NYSE) Risk Level *

Trailing PE Forward PE 8.5. Buy 5 Analysts. 1-Year Return: -39.3% 5-Year Return: -91.2%

Analyst's Notes. Argus Recommendations

OEF ishares S&P 100 A 93. The ishares S&P 100 Index Fund tracks a market-cap-weighted index of 100 largecap companies selected by the S&P Committee.

Attractiveness Ratings for The Approved Wright Investment List

IDHQ Invesco S&P International Developed Quality ETF

VIS Vanguard Industrials ETF

EWS ishares MSCI Singapore ETF

VBR Vanguard Small-Cap Value ETF

PY Principal Shareholder Yield Index ETF

Trailing PE Forward PE Buy 2 Analysts. 1-Year Return: -39.7% 5-Year Return: --

MTUM ishares Edge MSCI U.S.A. Momentum Factor ETF

Analyst's Notes. Argus Recommendations

hedge fund indexing September 2007

JPN Xtrackers Japan JPX-Nikkei 400 Equity ETF

ENY Invesco Canadian Energy Income ETF

KOR AdvisorShares KIM Korea Equity ETF

XLE Energy Select Sector SPDR Fund

ARK B 17. ARK Innovation ETF

FCVT First Trust SSI Strategic Convertible Securities ETF

JPN Xtrackers Japan JPX-Nikkei 400 Equity ETF

XLV Health Care Select Sector SPDR Fund

SDY SPDR S&P Dividend ETF

OQAL Oppenheimer Russell 1000 Quality Factor ETF

Transcription:

Stock Fundamentals as of May 7, 18 CYANOTECH Rating Hold Ticker CYAN Market Cap Designation Micro-cap Market Capitalization (Millions) $24.2 Price $4.08 52-Week High/Low $5.63/3.25 EPS (TTM) $0.31 P/E Ratio (TTM) 13.5 Dividend Yield 0.0% Price/Book Ratio 1.4 Price/Sales Ratio 0.7 30-Day Average Volume (Thousands) 8.1 Beta 0.25 Current Ratio 2.3 Short Interest Ratio N/A Shares Outstanding (Millions) 5.8 $5.50 $5.00 $4.50 $4.00 $3.50 0 Average Daily Volume in Thousands 50-Day Moving Average Jun '17 Jul Aug Sep Oct Nov Dec Jan '18 Feb Mar Apr Ratings 's Buy/Hold/Sell ratings are based on a combination of dynamic filters that determine which attributes of a stock are most predictive in the prevailing market and which stocks best reflect those attributes but are not yet rewarded. starts with an "extraction" process that uses the best performing filters to identify stocks having certain compelling attributes currently sought by the market. Then, a composite scoring process uses a weighted average of several key scores to quantify the relative likelihood of upside or downside price action. As a result, the Buy/Hold/Sell rating may, in certain cases, seem inconsistent with a simple average of the scores cited in this analysis. A BUY rating means the stock is expected to outperform its relevant benchmark substantially over the next 6 months. A SELL rating means the stock is expected to underperform its relevant benchmark substantially over the next 6 months. A rating means the stock is expected to perform in line with its relevant benchmark over the next 6 months. If a stock is rated, the investor should review the stock's history of ratings to see if it has recently changed to from BUY or SELL. If so, this indicates one of the following: (1) there has been a significant change in the stock's fundamentals, (2) the stock is already appropriately rewarded or punished by the market, or (3) there simply has been some recent price consolidation that warrants attention. A reading of 's analysis should identify which it is. More about on Page 3 's Market Cap Designations Large Cap Mid Cap Small Cap Micro Cap > $5.0 Billion $1.0 - $5.0 Billion $150 Million - $1.0 Billion < $150.0 Million Report prepared on May 8, 18 Page 1 Copyright 18 Systems LLC. All rights reserved. Company Profile Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Companys products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Earnings and Revenue Update: For the quarter ended December 31, 17, Cyanotech Corp reported earnings of $1.1 million or $0.19 per share compared with $0.5 million or $0.08 per share for the prior quarter and $-0.3 million or $-0.06 per share for the same quarter one year ago. Revenues were $9.2 million for the quarter ended December 31, 17 compared with $8.1 million for the prior quarter and $7.6 million for the same quarter one year ago. Last twelve months' earnings were $0.31 per share compared with $-0.89 per share a year ago. Last twelve months' revenues were $33.3 million compared with $33.0 million a year ago. Analysis CYAN gets a Hold rating from. Despite a strong value profile, the stock could not generate a Buy signal in this week's composite filtering process. Value: With a Value Score of 81.9, CYAN is one of the more desirable stocks with regard to valuation. At its current price, the stock is a superior candidate for value-minded investors who seek high potential gains with low downside risk. Growth: CYAN's score of 64.5 for the Growth Score indicates that the stock's growth prospects are somewhat above average. Momentum: With regard to momentum, CYAN receives a relatively low 39.4 for the Momentum Score. The score is a composite measure of price, earnings and group momentum. Timeliness: This stock has a Timeliness Score of 3.4. This is a composite measure of short-term and long-term price performance and long-term group performance. Analysis continued on Page 3

Current Scores Compared with Industry and Relevant Benchmark These scores compare various aspects of CYANOTECH with its industry and relevant benchmarks. The scores are percentile rankings from 0 to 99.9. Higher scores are better. We use a weighted average of several key scores to quantify the relative likelihood of upside or downside price action. Therefore, the rating may seem inconsistent with a simple average of the scores cited in this analysis. Growth Score: 64.5 CYAN 64.5 Industry 43.7 sp0 52.6 Value Score: 81.9 CYAN 81.9 Industry 51.2 sp0 43.3 The Growth Score reflects a company's historical and projected earnings growth, revenue and sales growth, projected cash flow, analyst activity, and changes in earnings estimates, each over various time periods. The higher the score, the better the combined performance of these key measures. With a Growth Score of 64.5, Cyanotech Corp is considerably higher than the average of its industry group, which has a Growth Score of 43.7. The Value Score measures the relationship between a company's stock price and its intrinsic value, as indicated by earnings and balance sheet attributes, with an emphasis on earnings. Also considered are cash flow measures and fundamental valuation ratios. With a Value Score of 81.9, Cyanotech Corp is substantially higher than the average of its industry group, which has a Value Score of 51.2. Momentum Score: 39.4 CYAN 39.4 Industry 37.1 sp0 52.0 Earnings Score: 93.3 CYAN 93.3 Industry 42.4 sp0 46.5 Balance Sheet Score: 58.5 CYAN 58.5 Industry 53.1 sp0 58.0 Fundamental Score: 83.9 CYAN 83.9 Industry 55.8 sp0 52.0 The Momentum Score measures a company's earnings and price momentum, evenly weighted, and augmented by group strength, money flow, and relative volume. Core technical factors include current price relative to periodic highs and moving averages. With a Momentum Score of 39.4, Cyanotech Corp is marginally higher than the average of its industry group, which carries a Momentum Score of 37.1. The Earnings Score assesses a company's overall earnings performance and projected outlook. Time periods include an average look-back of three years with an emphasis on the past four quarters and a forward look of one to five years. With a Earnings Score of 93.3, Cyanotech Corp is dramatically higher than the average of its industry group, which has a Earnings Score of 42.4. The Balance Sheet Score measures a company's liquidity and debt issues, as well as receivables and inventory quality. This score is used to assess relative risk associated with a stock: the lower the score, most likely the higher the inherent risk. With a Balance Sheet Score of 58.5, Cyanotech Corp is marginally higher than the average of its industry group, which carries a Balance Sheet Score of 53.1. The Fundamental Score is the broad measure of a company's financial health, including its balance sheet, cash flow, revenue, and earnings quality. With a Fundamental Score of 83.9, Cyanotech Corp is considerably higher than the average of its industry group, which carries a Fundamental Score of 55.8. Timeliness Score: 3.4 CYAN 3.4 Industry 38.8 sp0 57.3 The Timeliness Score is an assessment of a stock's short and long-term price strength as determined by various chart-based indicators and measures of group momentum and relative price performance. With a Timeliness Score of 3.4, Cyanotech Corp is well below the average of its industry group, which carries a Timeliness Score of 38.8. Peer Analysis This table compares CYAN with other similar-sized companies in the same industry group, focusing on 's growth, momentum and value scores, which represent the three main investing styles. The Peer Analysis chart compares CYAN's 2-year total return with the average 2-year total return of these companies. 2-Year Total Return -25% -50% -75% CYAN Peers Symbol Company Growth Score Momentum Score Value Score Market Cap.(M) CYAN CYANOTECH 64.5 39.4 81.9 $24.2 ARDM Aradigm Corp 70.7 87.3 66.7 $0.0 PTX Pernix Therapeutics Holdings Inc 70.1 84.2 61.7 $0.0 CLRB Cellectar Biosciences Inc 52.1 35.8 56.6 $0.0 SNOA Oculus Innovative Sciences Inc 74.5 62.8 69.4 $0.0 CUR Neuralstem Inc 83.5 94.8 39.4 $0.0 17 18 VTGN Vistagen Therapeutics Inc 51.4 53.5 46.2 $0.0 Report prepared on May 8, 18 Page 2 Copyright 18 Systems LLC. All rights reserved.

Historical Scores The recent histories of key scores provide insight into the stock's trends -- whether they are increasing or decreasing in strength in a particular area or simply holding steady. The scores are percentile rankings from 0 to 99.9, with higher scores better. Keep in mind that ratings may seem inconsistent with a simple average of these key scores because a weighted average of several key scores is used to quantify the relative likelihood of upside or downside price action. Growth Score: 64.5 37.3 Value Score: 81.9.8 76.8 71.6 26.9 64.5 Momentum Score: 39.4 65.5 58.3 81.9 2/6/18 3/6/18 4/3/18 Current Earnings Score: 93.3 14.8 96.4 98.3 58.5 57.7 39.4 Balance Sheet Score: 58.5 45.9 65.3 93.3 Fundamental Score: 83.9 49.2 41.3 72.0 58.5 Timeliness Score: 3.4 45.2.4 96.3 93.2 83.9 3.4 2/6/18 3/6/18 4/3/18 Current Report prepared on May 8, 18 Page 3 Copyright 18 Systems LLC. All rights reserved. Analysis continued from Page 1 Best Performing Filters: To determine the likelihood of near-term performance, builds and backtests "Smart Filters" to establish which caps, styles and attributes are drawing a premium in today's market. Currently, the three most predictive filters for the relevant segment are: Group Momentum Filter: The Group Momentum Filter measures industry group performance in multiple periods with an emphasis on the last three months and serves as a proxy for broader market sentiment toward a group or niche. Backtesting shows that the filter has earned a significant premium to its micro-cap benchmark over the past three months. CYAN scores 30.1 for this filter. Momentum Rank Change Filter: The Momentum Rank Change Filter measures short-term changes among key momentum measures, including earnings, price and group momentum. During the past 90 days, the filter significantly outperformed its micro-cap benchmark. CYAN scores 41.8 for this filter. Triple Rank Filter: The Triple Rank Filter considers earnings momentum, price momentum and group momentum, along with a factor that measures the flow of money into a stock. The filter has significantly outperformed its micro-cap benchmark during the last 90 days. CYAN scores 24.7 for this filter. In summary, CYAN is rated a Hold because it did not pass the most rigorous standards of 's backtested filtering process. This analysis should be considered in light of the recent behavior of the market, discussed below. What the Market Wants: July 15 To read this week's "What the Market Wants" go to the Blog at www.sabrient.com/blog/ Company Description Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Companys products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the bodys natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California. About Systems is an independent research firm providing statistical analysis of a company's fundamental data to investment professionals. We use a computer-driven, quantitative methodology to identify stocks that appear poised to outperform or underperform the market. The methodology was developed by an experienced research team led by David Brown, a former NASA scientist and retired CEO of Telescan and designer of its premier stock search program, ProSearch. The research team employs a scientific approach to the creation and testing of multi-factor filters. Each filter targets a key area of traditional stock analysis, including value, growth, momentum, fundamentals, earnings, balance sheet, and group strength. Using an

adaptive process, filters are continually tested and monitored to ensure that only the best performing filters are at work. Report prepared on May 8, 18 Page 4 Copyright 18 Systems LLC. All rights reserved.

's ratings begin with an extraction process in which each of the few best-performing filters scans the universe of equities to identify stocks having certain compelling attributes sought, but not sufficiently rewarded, by the current market. Then, a composite scoring system employs a broader set of "weighting" filters to rank the extracted stocks. To support individual investors, uses the same sophisticated methodology to provide individual stock reports on a universe of approximately 5,0 stocks. regularly tests the performance of its stock selections, using its primary list of published rankings and statistical techniques it believes appropriate. These recommendations have consistently outperformed relevant benchmarks across a broad range of investing styles, market caps, time frames and market conditions, demonstrating the robustness of 's proprietary methodology. While past performance is no guarantee of future results, believes it can maintain its strong performance through its rigorous, scientific approach to filter construction and ongoing backtesting within a dynamic and adaptive composite scoring system. For more information on and its performance, go to www.sabrient.com Disclaimer SmartStock research is provided for informational purposes only. It is neither a solicitation to buy nor an offer to sell these securities. The report is based upon data from sources believed to be reliable, but makes no representation as to the data's adequacy, accuracy, completeness or timeliness. The report does not address individual investment objectives or financial situations. The analysis used in preparing these reports may also be used in the preparation of other research products which may reflect distinct investment objectives. accepts no liability for any loss arising from any use of this report. This report is based solely on mathematical calculations and does not reflect any bias of individual analysts. provides no investment banking, consulting or other services to the subject company of this report. No employee is on the Board of Directors of the subject company, and no one at the subject company serves on the Board of Directors of Systems. or its employees may have long or short positions in the securities or other related investments of the company mentioned herein, but never more than one percent (1%) of the outstanding shares of any company covered by. No part of this document may be reproduced without the written permission of Systems. Report prepared on May 8, 18 Page 5 Copyright 18 Systems LLC. All rights reserved.